Is NVP-LDE 225 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use NVP-LDE 225? Is NVP-LDE 225 safe for nursing mother and child? Does NVP-LDE 225 extracts into breast milk? Does NVP-LDE 225 has any long term or short term side effects on infants? Can NVP-LDE 225 influence milk supply or can NVP-LDE 225 decrease milk supply in lactating mothers?
Answer by DrLact: About NVP-LDE 225 usage in lactation
No information is available on the clinical use of NVP-LDE 225 during breastfeeding. Because NVP-LDE 225 is 97% bound to plasma proteins, the amount in milk is likely to be low. However, its half-life is about 28 days and it might accumulate in the infant. The manufacturer recommends that breastfeeding be discontinued during NVP-LDE 225 therapy.
Alternate Drugs
Vincristine(Dangerous)
Tamoxifen(Dangerous)
Dasatinib(Unsafe)
Bevacizumab(Low Risk)
Gemcitabine(Dangerous)
Thioguanine(Dangerous)
Mitoxantrone(Dangerous)
Letrozole(Dangerous)
Dactinomycin(Dangerous)
Mercaptopurine(Safe)
Nilotinib(Unsafe)
Exemestane(Dangerous)
Erlotinib(Unsafe)
Hydroxyurea(Low Risk)
Trastuzumab(Unsafe)
Etoposide(Dangerous)
Docetaxel(Dangerous)
Doxorubicin(Dangerous)
Pazopanib(Unsafe)
Cyclophosphamide(Dangerous)
Imatinib(Unsafe)
Ipilimumab(Unsafe)
Cisplatin(Unsafe)
Cetuximab(Unsafe)
Busulfan(Dangerous)
Nivolumab(Unsafe)
Azelaic Acid(Safe)
Carboplatin(Dangerous)
Vinblastine(Dangerous)
Paclitaxel(Dangerous)
Bleomycin(Dangerous)
Cladribine(Dangerous)
Fluorouracil(Dangerous)
Vinorelbine(Dangerous)
Alemtuzumab(Low Risk)
Dacarbazine(Dangerous)
Rituximab(Low Risk)
Dasatinib(Unsafe)
Orlistat(Low Risk)
Gemcitabine(Dangerous)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Allopurinol(Safe)
Nilotinib(Unsafe)
Erlotinib(Unsafe)
Pazopanib(Unsafe)
Imatinib(Unsafe)
Dasatinib(Unsafe)